Meclizine Hydrochloride Tablet, Chewable
Product Images NDC 68071-2574

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 68071-2574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2574 2)

Pdp (68071 2574 2)
This is a description of a medication called Meclizine 25mg. Each chewable tablet contains Meclizine Hydrochloride 25mg. It is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is not recommended for children under 12 years old unless directed by a doctor. People who have glaucoma, breathing problems, enlarged prostate gland, or taking sedatives or tranquillizers are advised to seek advice from a doctor or pharmacist before taking the medication. Additionally, people using the medication should not exceed the recommended dosage, may experience drowsiness and should avoid alcoholic drinks. The medication is pink and scored and is packaged in a bottle. Lot number, NDC, MFR NDC, Serial#, and Exp. date information is also provided on the package. People may report any side effects to the FDA. The medication must be stored at controlled temperature 68-77°F and kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.